TENS Therapy Shows Sustained Pain Relief for Fibromyalgia Patients in Large Real-World Trial
Key Insights
A large real-world clinical trial involving 384 fibromyalgia (search) patients across 28 clinics found that adding TENS (search) to physical therapy significantly reduced movement-evoked pain by 1.2 points on a 10-point scale compared to physical therapy alone.
The study demonstrated that TENS (search) therapy specifically targets both movement-associated pain and fatigue, with 72% of patients reporting improvement compared to 51% receiving physical therapy only.
Unlike traditional pain medications that lose effectiveness over time, TENS (search) maintained its therapeutic benefits for at least six months, with 81% of participants finding it helpful and 55% using it daily at the study's end.
A groundbreaking real-world clinical trial has demonstrated that transcutaneous electrical nerve stimulation (search) (TENS (search)) provides sustained relief for fibromyalgia (search) patients when combined with physical therapy, offering new hope for the millions struggling with this chronic pain (search) condition.
The Fibromyalgia (search) TENS (search) in Physical Therapy (FM-TIPS) study, led by Kathleen Sluka, PT, PhD, at University of Iowa Health Care, represents the first real-world trial of TENS for fibromyalgia. Published in JAMA Network Open, the research involved 384 participants across 28 outpatient physical therapy clinics in six Midwest health care systems.
Significant Pain Reduction Achieved
The study found that adding TENS (search) to standard physical therapy resulted in a clinically meaningful reduction in movement-evoked pain. At the 60-day primary endpoint, participants receiving TENS therapy experienced a 1.2-point greater reduction in movement-evoked pain on a 10-point scale compared to those receiving physical therapy alone (95% CI, −1.6 to −0.7; d = 0.46).
"It is one of the few treatments that specifically targets movement-evoked pain and fatigue, which are major barriers to participation in daily activities," says Sluka, UI professor of physical therapy and rehabilitation science.
The treatment demonstrated a clear dose-response relationship, with participants who used TENS (search) daily for 60 days achieving the best outcomes. Notably, 72% of patients in the TENS group reported improvement compared to 51% in the physical therapy-only group (P = .001).
Breakthrough in Fatigue Management
Perhaps most significantly, the study showed that TENS (search) therapy also reduced fatigue—a primary symptom of fibromyalgia (search) that has few effective treatments. "We were excited to see that patients also had less fatigue," Sluka noted. "Right now, there are no good treatments for fatigue. So, the fact that we had anything that touched the fatigue was pretty powerful."
The research addressed a fundamental paradox in fibromyalgia (search) care: while exercise is considered the best medicine for the condition, movement itself causes agonizing pain and crushing fatigue for patients.
Real-World Effectiveness and Safety
Unlike many laboratory-based studies, FM-TIPS was conducted in everyday clinical settings with participants of diverse ages, education levels, and socioeconomic backgrounds. Nearly 50% of participants were from rural areas, demonstrating the treatment's broad applicability.
The study protocol required participants in the TENS (search) group to use the device for two hours daily for six months, with electrodes placed on the upper and lower back delivering mixed frequency signals at the strongest tolerable intensity.
Safety data showed no serious adverse events, with only 30% of participants experiencing minor adverse events over the six-month study period. This compares favorably to FDA-approved fibromyalgia (search) medications, which often carry significant side effect profiles.
Sustained Long-Term Benefits
Unlike pain medications that can lose effectiveness over time due to tolerance, TENS (search) maintained its therapeutic benefits throughout the study period. At six months, 81% of participants found TENS helpful, and 55% continued using it daily.
Dana Dailey, PT, PhD, the study's first author and UI assistant research scientist, emphasized that TENS (search) works best as part of a comprehensive treatment approach. "Using TENS on its own will not give the same benefits," Dailey explains. "However, the study shows that TENS provides an added benefit on top of any relief from other treatments."
Clinical Implementation and Accessibility
The research demonstrates that TENS (search) offers several advantages for fibromyalgia (search) management: it's safe, inexpensive, readily available, and can be used as a self-management tool. The treatment showed effectiveness even when participants were simultaneously using pain medications and receiving physical therapy.
"Often, when you move a randomized, controlled clinical trial into a real-world setting, it doesn't work because there are too many confounding factors. But this intervention still works," Sluka observed. "Not only did the treatment reduce movement pain and fatigue during the testing period, but patients continued to use it at six months."
The study's design allowed the physical therapy-only group to receive TENS (search) devices after the 60-day primary endpoint, and these participants showed the same improvements as the original TENS group, further validating the treatment's effectiveness.
Addressing an Unmet Medical Need
Fibromyalgia (search) affects approximately 4% to 7% of the population and significantly impacts physical function, cognitive abilities, and sleep quality. The condition's hallmark features include chronic widespread pain and whole-body fatigue that interferes with daily activities and contributes to concentration difficulties.
The FM-TIPS study was funded as part of the HEAL Initiative by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (search), reflecting the urgent need for effective non-pharmacological treatments for chronic pain (search) conditions.
This research builds on decades of work by Sluka and her colleagues studying the biological mechanisms of TENS (search) and developing optimal stimulation parameters for treating chronic pain (search) and fatigue. The successful translation from controlled laboratory conditions to real-world clinical practice represents a significant advancement in fibromyalgia (search) care.